| Teva Pharma AG - Denosumab-Teva onco 120 mg / 1.7 ml, Injektionslösung |
| 70132 | | 01 | | Denosumab-Teva onco 120 mg / 1.7 ml | | Injektionslösung | | M05BX04 | | Denosumab | | 10.12.2025 | | |
|
| Composition |
| denosumabum 120 mg, natrii acetas trihydricus corresp. natrium 0.49 mg, acidum aceticum glaciale, sorbitolum 79.9 mg, polysorbatum 20, aqua ad iniectabile q.s. ad solutionem pro 1.7 ml. |
| Packungsbestandteile |
| Injection solution | | | | | | | | Active Agent | Dose |
|---|
| Denosumabum | 120mg / 1.7ml |
| | BAG: Active Agent | Dose |
|---|
| Denosumabum | 120 mg |
| | | | Inactive agents | Dose |
|---|
| Acidum Aceticum Glaciale | | | Natrii Acetas Trihydricus | | | Polysorbatum 20 | | | Sorbitol | 79.9mg / 1.7ml |
| |
|
| Package number | Package Size | EFP | CP | Category | SL | Out of trade (MedRef) |
|---|
| 001 | | 172.04 | 210.45 | A | | No | | 002 | 3 | | | A | | Yes |
|
